Flarin Holdings completes first round of fundraising for new drug
Flarin Holdings Limited has completed its first round of fund-raising by IW Capital. Flarin Holdings was recently demerged from Infirst Healthcare Limited in order to provide greater focus on the rapid commercialisation of Flarin. Flarin is a unique and patent protected lipid formulated ibuprofen which at a dose of 1200